Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Adenocarcinoma D000230 166 associated lipids
Body Weight D001835 333 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Cattle Diseases D002418 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Endometriosis D004715 29 associated lipids
Genital Neoplasms, Male D005834 3 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Moore GD et al. Inhibition of sperm migration, fertilization and implantation in rats by precoital intrauterine administration of gossypol or nonoxynol-9. 1988 Contraception pmid:2835205
Sakesena SK et al. Gossypol: its toxicological and endocrinological effects in male rabbits. 1981 Contraception pmid:7297071
Tso WW and Lee CS Variations of gossypol sensitivity in boar spermatozoal electron transport chain segments. 1981 Contraception pmid:7318437
Ojha P et al. Effect of antispermatogenic agents on cell marker enzymes of rat Sertoli cells in vitro. 2006 Contraception pmid:16371305
Frick J et al. Clinical microdose study of gossypol: effect on sperm motility and renal function. 1988 Contraception pmid:3370988
Drayer DE and Reidenberg MM Gossypol and Na+, K+ ATPase from human erythrocytes. 1988 Contraception pmid:2848657
Xue SP et al. Evaluation of the renal tubulo-toxic effect of gossypol by urinary protein analysis with SDS-polyacrylamide gel electrophoresis. 1988 Contraception pmid:3370989
Beaudoin AR A developmental toxicity evaluation of gossypol. 1988 Contraception pmid:3370993
Yang ZJ et al. Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men. 2004 Contraception pmid:15325889
Kumar M et al. Gossypol-induced hypokalemia and role of exogenous potassium salt supplementation when used as an antispermatogenic agent in male langur monkey. 1997 Contraception pmid:9408707
Wu DF and Reidenberg MM Stereoselective interaction between gossypol and rat plasma. 1990 Contraception pmid:2335102
Lin YC et al. Effect of gossypol on thyroid hormones in young female rats. 1990 Contraception pmid:2335106
Kim I et al. Inhibition of lactate dehydrogenase-X by imino-derivatives of gossypol:structure activity relationship. 1987 Contraception pmid:3608484
Sinha Hikim AP and Hoffer AP Quantitative analysis of germ cells and Leydig cells in rat made infertile with gossypol. 1987 Contraception pmid:3621939
Polsky B et al. Inactivation of human immunodeficiency virus in vitro by gossypol. 1989 Contraception pmid:2473865
Wang C and Yeung RT Gossypol and hypokalaemia. 1985 Contraception pmid:3910352
Han ML et al. Gossypol in the treatment of endometriosis and uterine myoma. 1987 Contrib Gynecol Obstet pmid:3121251
Verma PC et al. Efficient production of gossypol from hairy root cultures of cotton (Gossypium hirsutum L.). 2009 Curr Pharm Biotechnol pmid:19751178
Jensen JT Male contraception. 2002 Curr Womens Health Rep pmid:12215306
Brozic P et al. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. 2008 Curr. Med. Chem. pmid:18220769
Kawanishi K et al. Aldose reductase inhibitors from the nature. 2003 Curr. Med. Chem. pmid:12871134
Vander Jagt DL et al. Gossypol: prototype of inhibitors targeted to dinucleotide folds. 2000 Curr. Med. Chem. pmid:10702620
Kovacic P Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transfer. 2003 Curr. Med. Chem. pmid:14529461
Bodur C and Basaga H Bcl-2 inhibitors: emerging drugs in cancer therapy. 2012 Curr. Med. Chem. pmid:22414090
VISWESWARA RAO K and VASUDEVA SARMA R Occurrence of gossypol. 1945 Curr. Sci. pmid:21007609
Graier WF et al. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. 1996 Diabetes pmid:8826976
Aripov UA et al. [Immunodepressive properties of the drug "Batriden" in experiments on parabionts]. 1975 Dokl. Akad. Nauk SSSR pmid:1140070
Krasil'nikov OV et al. [Dependence of the protonophore and channel-forming capacity of gossypol on the pH]. 1985 Dokl. Akad. Nauk SSSR pmid:2408838
Basini G et al. Gossypol, a polyphenolic aldehyde from cotton plant, interferes with swine granulosa cell function. 2009 Domest. Anim. Endocrinol. pmid:19342192
Reynolds JM and Tone JN Subchronic oral administration of gossypol-acetic acid (GAA) alters the distribution and utilization of radioiron in male rats. 1988 Drug Chem Toxicol pmid:3402348
Tone JN and Jensen DR Radioiron utilization and gossypol acetic acid in male rats. 1985 Drug Chem Toxicol pmid:4017900
Lagerlöf RK and Tone JN The effect of gossypol acetic acid on female reproduction. 1985 Drug Chem Toxicol pmid:4092619
Ren T et al. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer. 2015 Drug Des Devel Ther pmid:26089640
Ren T et al. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway. 2014 Drug Des Devel Ther pmid:25548514
Qian C et al. Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor. 2014 Drug Des Devel Ther pmid:24872679
Matlin SA Prospects for pharmacological male contraception. 1994 Drugs pmid:7533693
Wu D An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. 1989 Drugs pmid:2680434
Gombe S A review of the current status in male contraceptive studies. 1983 East Afr Med J pmid:6354690
Suzuki H et al. [Studies on naturally occurring toxic substances (III). Determination of gossypol in seed kernels of cotton plants by high performance liquid chromatography]. 1986 Eisei Shikenjo Hokoku pmid:3567428
Sabirova FM et al. [Immunomodulating effect of the novel water-soluble gossypol derivative Mebavin in adjuvant arthritis]. 2004 Mar-Apr Eksp Klin Farmakol pmid:15188763
Sabirova FM and Madaminov AA [Anti-inflammatory activity of the novel water soluble gossipol derivative mebavine]. 2003 Nov-Dec Eksp Klin Farmakol pmid:14743712
Colman N et al. Non-mutagenicity of gossypol in the Salmonella/mammalian-microsome plate assay. 1979 Environ Mutagen pmid:399915
Gao F et al. Interactive effects of elevated CO2 and cotton cultivar on tri-trophic interaction of Gossypium hirsutum, Aphis gossyppii, and Propylaea japonica. 2008 Environ. Entomol. pmid:18348793
Stipanovic RD et al. Effect of racemic, (+)- and (-)-gossypol on survival and development of Heliothis virescens larvae. 2008 Environ. Entomol. pmid:19036185
Majumdar SK et al. Genotoxic effects of gossypol acetic acid on cultured murine erythroleukemia cells. 1991 Environ. Mol. Mutagen. pmid:1915316
Liang JC and Ye WS Clastogenicity of a male contraceptive, gossypol, in mammalian cell cultures with and without the metabolic activation by S9 mix. 1985 Environ. Res. pmid:3967635
Aneja R et al. Modulatory influence of tin-protoporphyrin on gossypol-induced alterations of heme oxygenase activity in male Wistar rats. 2003 Jul-Sep Eur J Drug Metab Pharmacokinet pmid:14527098
Akinola OB et al. Proteinaceous diet inhibits gossypol-induced spermatotoxicity. 2006 Jul-Sep Eur J Histochem pmid:16920644
Dao VT et al. Cytotoxicity of enantiomers of gossypol Schiff's bases and optical stability of gossypolone. 2004 Eur J Med Chem pmid:15236842
Zhang L et al. Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling. 2009 Eur J Med Chem pmid:19447525